Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Feb 20, 2014 goldstein joseph l Director Sell 1,000 326.96 - 327.17
Feb 25, 2014 goldstein joseph l Director Sell 1,000 338.86
Apr 6, 2016 goldstein joseph l Director Option Execute 1,000 177.82
Dec 17, 2012 mccorkle douglas s Officer Automatic Sell 1,000 178.19 - 179.45
Feb 26, 2016 ryan arthur f Director Disposition (Non Open Market) 1,000 n/a
May 24, 2016 ryan arthur f Director Sell 1,000 396.64
May 24, 2016 ryan arthur f Director Disposition (Non Open Market) 1,000 n/a
May 28, 2015 stahl neil Officer Disposition (Non Open Market) 1,000 n/a
Jan 14, 2011 roberts william Officer Option Execute 1,188 9.49
Dec 18, 2012 aberman michael s Officer Option Execute 1,200 24.00
Jan 12, 2011 vagelos p roy Officer Disposition (Non Open Market) 1,203 n/a
Jan 12, 2011 vagelos p roy Officer Acquisition (Non Open Market) 1,203 n/a
Apr 4, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,215 n/a
Jan 8, 2013 vagelos p roy Officer Disposition (Non Open Market) 1,254 n/a
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 5, 2012 baker charles a Director Option Execute 1,286 15.01
Jan 2, 2009 goldberg murray a Officer Option Execute 1,300 7.41
May 27, 2015 ingram robert alexander Director Sell 1,379 513.39
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Oct 9, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,392 n/a
Showing 61-80 of 1043 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)